Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases

Background. Methotrexate is renally excreted. HDMTX (high dose-methotrexate)-induced acute kidney injury (AKI) is a non-oliguric decrease in glomerular filtration rate (GFR) heralded by an acute rise in serum creatinine. Moreover, AKI is also a frequent complication of COVID-19. Among our patients t...

Full description

Bibliographic Details
Main Authors: Olga Nigro, Cristina Meazza, Elisabetta Schiavello, Veronica Biassoni, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Virginia Livellara, Gabriele Papagni, Maura Massimino
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/10/2/331
_version_ 1797621684483653632
author Olga Nigro
Cristina Meazza
Elisabetta Schiavello
Veronica Biassoni
Nadia Puma
Luca Bergamaschi
Giovanna Gattuso
Giovanna Sironi
Virginia Livellara
Gabriele Papagni
Maura Massimino
author_facet Olga Nigro
Cristina Meazza
Elisabetta Schiavello
Veronica Biassoni
Nadia Puma
Luca Bergamaschi
Giovanna Gattuso
Giovanna Sironi
Virginia Livellara
Gabriele Papagni
Maura Massimino
author_sort Olga Nigro
collection DOAJ
description Background. Methotrexate is renally excreted. HDMTX (high dose-methotrexate)-induced acute kidney injury (AKI) is a non-oliguric decrease in glomerular filtration rate (GFR) heralded by an acute rise in serum creatinine. Moreover, AKI is also a frequent complication of COVID-19. Among our patients treated with HDMTX, some of these developed AKI during SARS-CoV-2 infection. Therefore, we wondered whether our patients’ kidney failure might have been triggered by their underlying SARS-CoV-2 positivity. Methods. Data were collected from the database at the Pediatric Oncology Unit of the Istituto Nazionale dei Tumori in Milan (Italy) regarding patients who matched the following selective criteria: (a) treatment with HDMTX during the pandemic period; (b) SARS-CoV-2 infection during the treatment; (c) development of AKI during HDMTX treatment and SARS-CoV-2 infection. Results. From March 2020 to March 2022, a total of 23 patients were treated with HDMTX; 3 patients were treated with HDMTX during SARS-CoV-2 infection and all 3 developed AKI. Conclusions. Clinical manifestations associated with this virus are many, so we are not yet able to lower our guard and rule out this infection as a cause of clinical manifestations with any certainty.
first_indexed 2024-03-11T09:00:28Z
format Article
id doaj.art-f442e099005241aea307056d05e73167
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-11T09:00:28Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-f442e099005241aea307056d05e731672023-11-16T19:49:22ZengMDPI AGChildren2227-90672023-02-0110233110.3390/children10020331Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three CasesOlga Nigro0Cristina Meazza1Elisabetta Schiavello2Veronica Biassoni3Nadia Puma4Luca Bergamaschi5Giovanna Gattuso6Giovanna Sironi7Virginia Livellara8Gabriele Papagni9Maura Massimino10Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyDepartment of Anesthesia and Critical Care, Fondazione IRCCS Istituto Tumori di Milano, 20133 Milan, ItalyPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyBackground. Methotrexate is renally excreted. HDMTX (high dose-methotrexate)-induced acute kidney injury (AKI) is a non-oliguric decrease in glomerular filtration rate (GFR) heralded by an acute rise in serum creatinine. Moreover, AKI is also a frequent complication of COVID-19. Among our patients treated with HDMTX, some of these developed AKI during SARS-CoV-2 infection. Therefore, we wondered whether our patients’ kidney failure might have been triggered by their underlying SARS-CoV-2 positivity. Methods. Data were collected from the database at the Pediatric Oncology Unit of the Istituto Nazionale dei Tumori in Milan (Italy) regarding patients who matched the following selective criteria: (a) treatment with HDMTX during the pandemic period; (b) SARS-CoV-2 infection during the treatment; (c) development of AKI during HDMTX treatment and SARS-CoV-2 infection. Results. From March 2020 to March 2022, a total of 23 patients were treated with HDMTX; 3 patients were treated with HDMTX during SARS-CoV-2 infection and all 3 developed AKI. Conclusions. Clinical manifestations associated with this virus are many, so we are not yet able to lower our guard and rule out this infection as a cause of clinical manifestations with any certainty.https://www.mdpi.com/2227-9067/10/2/331SARS-CoV-2COVID-19methotrexatepediatricrenal failureAKI
spellingShingle Olga Nigro
Cristina Meazza
Elisabetta Schiavello
Veronica Biassoni
Nadia Puma
Luca Bergamaschi
Giovanna Gattuso
Giovanna Sironi
Virginia Livellara
Gabriele Papagni
Maura Massimino
Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
Children
SARS-CoV-2
COVID-19
methotrexate
pediatric
renal failure
AKI
title Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
title_full Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
title_fullStr Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
title_full_unstemmed Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
title_short Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
title_sort acute kidney injury with sars cov 2 infection in pediatric patients receiving high dose methotrexate chemotherapy a report of three cases
topic SARS-CoV-2
COVID-19
methotrexate
pediatric
renal failure
AKI
url https://www.mdpi.com/2227-9067/10/2/331
work_keys_str_mv AT olganigro acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT cristinameazza acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT elisabettaschiavello acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT veronicabiassoni acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT nadiapuma acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT lucabergamaschi acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT giovannagattuso acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT giovannasironi acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT virginialivellara acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT gabrielepapagni acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases
AT mauramassimino acutekidneyinjurywithsarscov2infectioninpediatricpatientsreceivinghighdosemethotrexatechemotherapyareportofthreecases